ATLAS Mara Limited Announces Update on Standstill and Statement regarding TLG
Key Highlights Atlas Mara and the consenting creditors under the recently announced Standstill continue constructive…
Month: February 2021
Meeting with a Visionary | Oduwa Coin Creator and Indigenous Cryptocurrency Innovator, Mr. Bright Enabulele
SHERIDAN, WY / ACCESSWIRE / February 17, 2021 / With an aim to become the…
Amex Discovers Additional High Grade Gold Structure Grading 58.25 g/t Au over 3.90 m on the Northern Normetal Fault and Reports 32.99 g/t Au over 4.50 m at High Grade Zone at Perron
MONTREAL, QC / ACCESSWIRE / February 17, 2021 / Amex Exploration Inc. (“Amex or the Company”) (TSXV:AMX)(FRA:MX0)(OTCQX:AMXEF)…
Endace Named 2021 TAG Cyber Distinguished Vendor
London, UK – February 17th, 2021 – Packet capture and high-speed network recording authority Endace…
REaD Group supports the Trussell Trust in its fundraising efforts
Data-led insight delivers greater understanding of donors to support charity’s growth London, 17 February 2021…
Trading in Novo Nordisk shares by board members, executives and associated persons on 15 February 2021
Bagsværd, Denmark, 17 February 2021 — This document discloses the data of the transaction(s) made…
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
New agreement brings total supply to the European Union to 500 million doses, with delivery…
Innate Pharma to participate in the 10th Annual SVB Leerink Global Healthcare Conference
Marseille, Feb. 17, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH – ISIN:…
Innate Pharma to Participate in the 10th Annual SVB Leerink Global Healthcare Conference
MARSEILLE, France, Feb. 17, 2021 (GLOBE NEWSWIRE) — Innate Pharma SA (Euronext Paris: IPH –…
Novartis and the Bill & Melinda Gates Foundation collaborate to discover and develop an accessible in vivo gene therapy for sickle cell disease
Project brings together Novartis drug discovery and gene therapy expertise and funding support from the…
Biophytis Announces Expansion of Patient Recruitment for Part 2 of the Phase 2-3 COVA Trial (“COVA Study”) Following Regulatory Authorities Approvals in France and Belgium
Clinical centers in France and Belgium will begin recruitment for Part 2 of the COVA…
Aeterna Zentaris Increases Previously Announced Bought Deal Offering of Common Shares to $29.7 Million
CHARLESTON, S.C., Feb. 16, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
Addex Provides Trading Update and Completes 2020 with Strong Cash Position of CHF18.7 million
Geneva, Switzerland, February 17, 2021 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical…
ObsEva to Present at the SVB Leerink 10th Annual Global Healthcare Conference
Geneva, Switzerland and Boston, MA – February 17, 2021 – ObsEva SA (NASDAQ: OBSV…
Wave Life Sciences to Present at the 10th Annual SVB Leerink Global Healthcare Conference
CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Aeterna Zentaris Announces $10.0 Million Bought Deal Offering of Common Shares
CHARLESTON, S.C., Feb. 16, 2021 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS)…
GenMark Diagnostics to Participate in the Cowen 41st Annual Health Care Conference
CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) — GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or…
Travere Therapeutics to Report Fourth Quarter and Full Year 2020 Financial Results
SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced…
Medexus to Present at the Winter Wonderland Conference- Best Ideas from the Buy-Side
TORONTO, CHICAGO and MONTREAL, Feb. 16, 2021 (GLOBE NEWSWIRE) — Medexus Pharmaceuticals Inc. (the “Company”…
ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 16, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…